116 related articles for article (PubMed ID: 9010608)
1. Peroxynitrite inhibition of nitric oxide synthases.
Pasquet JP; Zou MH; Ullrich V
Biochimie; 1996; 78(8-9):785-91. PubMed ID: 9010608
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitric oxide synthase isoforms by porphyrins.
Wolff DJ; Naddelman RA; Lubeskie A; Saks DA
Arch Biochem Biophys; 1996 Sep; 333(1):27-34. PubMed ID: 8806750
[TBL] [Abstract][Full Text] [Related]
3. Fire ant venom alkaloid, isosolenopsin A, a potent and selective inhibitor of neuronal nitric oxide synthase.
Yi GB; McClendon D; Desaiah D; Goddard J; Lister A; Moffitt J; Meer RK; deShazo R; Lee KS; Rockhold RW
Int J Toxicol; 2003; 22(2):81-6. PubMed ID: 12745988
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1996 Jan; 325(2):227-34. PubMed ID: 8561501
[TBL] [Abstract][Full Text] [Related]
7. Effects of nitric oxide and peroxynitrite on endotoxin-induced leukocyte adhesion to endothelium.
Lelamali K; Wang W; Gengaro P; Edelstein C; Schrier RW
J Cell Physiol; 2001 Sep; 188(3):337-42. PubMed ID: 11473360
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine.
Galea E; Regunathan S; Eliopoulos V; Feinstein DL; Reis DJ
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):247-9. PubMed ID: 8645212
[TBL] [Abstract][Full Text] [Related]
9. Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds.
Griscavage JM; Hobbs AJ; Ignarro LJ
Adv Pharmacol; 1995; 34():215-34. PubMed ID: 8562436
[TBL] [Abstract][Full Text] [Related]
10. Peroxynitrite inhibits inducible (type 2) nitric oxide synthase in murine lung epithelial cells in vitro.
Robinson VK; Sato E; Nelson DK; Camhi SL; Robbins RA; Hoyt JC
Free Radic Biol Med; 2001 May; 30(9):986-91. PubMed ID: 11316578
[TBL] [Abstract][Full Text] [Related]
11. High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation.
El-Remessy AB; Abou-Mohamed G; Caldwell RW; Caldwell RB
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3135-43. PubMed ID: 12824263
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase.
Zembowicz A; Hatchett RJ; Radziszewski W; Gryglewski RJ
J Pharmacol Exp Ther; 1993 Dec; 267(3):1112-8. PubMed ID: 7505326
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of thiol-modulating agents on endothelial NO bioactivity.
Huang A; Xiao H; Samii JM; Vita JA; Keaney JF
Am J Physiol Cell Physiol; 2001 Aug; 281(2):C719-25. PubMed ID: 11443071
[TBL] [Abstract][Full Text] [Related]
15. Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells.
Bachetti T; Comini L; Curello S; Bastianon D; Palmieri M; Bresciani G; Callea F; Ferrari R
J Mol Cell Cardiol; 2004 Nov; 37(5):939-45. PubMed ID: 15522271
[TBL] [Abstract][Full Text] [Related]
16. Cellular and enzymatic studies of N(omega)-propyl-l-arginine and S-ethyl-N-[4-(trifluoromethyl)phenyl]isothiourea as reversible, slowly dissociating inhibitors selective for the neuronal nitric oxide synthase isoform.
Cooper GR; Mialkowski K; Wolff DJ
Arch Biochem Biophys; 2000 Mar; 375(1):183-94. PubMed ID: 10683266
[TBL] [Abstract][Full Text] [Related]
17. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES
J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974
[TBL] [Abstract][Full Text] [Related]
18. Molecular actions of a Mn(III)Porphyrin superoxide dismutase mimetic and peroxynitrite scavenger: reaction with nitric oxide and direct inhibition of NO synthase and soluble guanylyl cyclase.
Pfeiffer S; Schrammel A; Koesling D; Schmidt K; Mayer B
Mol Pharmacol; 1998 Apr; 53(4):795-800. PubMed ID: 9547373
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the inhibition of neuronal nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM).
Handy RL; Moore PK
Life Sci; 1997; 60(25):PL389-94. PubMed ID: 9194695
[TBL] [Abstract][Full Text] [Related]
20. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase.
Wolff DJ; Lubeskie A
Arch Biochem Biophys; 1995 Jan; 316(1):290-301. PubMed ID: 7530937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]